IP Library Granted Patent US 12,544,346
Granted Patent B2
US 12,544,346 · App. 17/629,197 · Granted Feb 10, 2026

Aqueous antiseptic composition having improved antibacterial persistence comprising chlorhexidine or derivative thereof and fabric type antiseptic comprising same

Inventors: Bae Young Kim (Seoul, KR); Dong Il Lee (Bucheon-si, KR); Eun Kyoung Lee (Hwaseong-si, KR); Min Hee Kang (Pyeongtaek-si, KR); Jae Min Cho (Seoul, KR); Joon Gyo Oh (Suwon-si, KR); Sang Man Lee (Anyang-si, KR)
Assignees: HUONS CO., LTD.; HUONS MEDITECH CO., LTD.
A61K31/155A61K9/0014A61K9/7007A61K47/14A61K47/34
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,544,346
App. No.
17/629,197
Granted
Feb 10, 2026
Kind
B2
Abstract

The present invention relates to: an aqueous (a water-soluble) antiseptic composition having improved antibacterial persistence comprising chlorhexidine or a derivative thereof and a silicon-based emulsifier; and a fabric type antiseptic comprising same. As the chlorhexidine or the derivative thereof is highly soluble and stable and well dispersed in an aqueous phase, the composition can exhibit excellent absorption efficiency when applied onto the skin and can ultimately maximize a cumulative emission amount of chlorhexidine or the derivative thereof. In addition, the use of the polyglyceryl fatty acid ester allows sustained release of chlorhexidine or the derivative thereof, thereby sustaining the antibacterial effect for a long time.

Claims (13)

1 . A water-soluble antiseptic composition having antibacterial persistence, comprising chlorhexidine or salt thereof;

silicone-based emulsifier; and

one or more PEG-based glyceryl fatty acid esters having a hydrophile-lipophile balance (HLB) of 8 to 12, which is selected from the group consisting of PEG-23 glyceryl cocoate, PEG-7 glyceryl cocoate, PEG-20 glyceryl triisostearate, and PEG-15 glyceryl monostearate,

wherein the water-soluble antiseptic composition comprises 0.1 to 10 g of the chlorhexidine or salt thereof, 0.01 to 1 g of the silicone-based emulsifier, and 0.01 to 0.5 g of the PEG-based glyceryl fatty acid esters with respect to 100 mL of the water-soluble antiseptic composition.

2 . The composition of claim 1 , wherein the chlorhexidine or a salt thereof is one or more selected from the group consisting of chlorhexidine, chlorhexidine gluconate, chlorhexidine dihydrochloride, and chlorhexidine diacetate.

3 . The composition of claim 1 , wherein the silicone-based emulsifier is one or more selected from the group consisting of simethicone, dimethicone, and methicone.

4 . The composition of claim 1 , wherein the composition has pH 4.5 to pH 6.5.

5 . The composition of claim 1 , wherein a 50% cumulative mass particle size distribution diameter (D50) of particles in the water-soluble antiseptic composition is 0.1 to 10 μm, a polydispersity index (PDI) thereof is 0.1 to 0.7, and an absolute value of zeta-potential is 20.0 mV or less.

6 . The composition of claim 1 , wherein when 10 mL of the water-soluble antiseptic composition is applied to a skin sample and dried for 5 minutes, a cumulative release amount of the chlorhexidine or a salt thereof for 10 minutes is 90 wt % or more.

7 . A fabric-type antiseptic having antibacterial persistence, comprising the water-soluble antiseptic composition of claim 1 coated on or impregnated into a fabric base.

8 . The antiseptic of claim 7 , wherein the fabric base is one or more selected from the group consisting of non-woven fabrics, fabrics, knitted fabrics, cotton, a sheet, hemostatic gauze, a band, a dressing, a suture, and a tape.

9 . The antiseptic of claim 8 , wherein the non-woven fabrics one or more materials selected from the group consisting of rayon, polyethylene terephthalate, cotton, bamboo fiber, pulp, polyester, and polypropylene.

10 . The antiseptic of claim 7 , wherein, with respect to the total content of the chlorhexidine or a salt thereof, a content of the chlorhexidine or a salt thereof after the fabric-type antiseptic is stored for 3 months under long-term conditions of temperature 25° C. and relative humidity 60% is 99 wt % or more, and a content of the chlorhexidine or a salt thereof after the fabric-type antiseptic is stored for 3 months under accelerated conditions of temperature 40° C. and relative humidity 75% is 95 wt % or more.

Assignments (3)
CHANGE OF NAME Recorded Sep 20, 2022
From: HUONS MEDICARE CO., LTD.
To: HUONS MEDITECH CO., LTD.
Reel/Frame 061481/0577 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2022
From: LEE, SANG MAN
To: HUONS CO., LTD.; HUONS MEDICARE CO., LTD.
Reel/Frame 059820/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 21, 2022
From: KIM, BAE YOUNG; LEE, DONG IL; LEE, EUN KYOUNG; KANG, MIN HEE; CHO, JAE MIN; OH, JOON GYO
To: HUONS CO., LTD.; HUONS MEDICARE CO., LTD.
Reel/Frame 058728/0195 →
Priority Claims (1)
KR 10-2019-0088288 · Jul 22, 2019 · national
Continuity (1)
Related Publication 20220249407A1 · Aug 11, 2022
References Cited (17)
US 20030175333A1 · Shefer · 2003 [cited by examiner]
US 20040191274A1 · Grayson et al. · 2004 [cited by applicant]
US 20070025948A1 · Saito · 2007 [cited by applicant]
US 20090186943A1 · Ikeda et al. · 2009 [cited by applicant]
US 20140343158A1 · Fusco · 2014 [cited by applicant]
US 20170319515A1 · Shabto · 2017 [cited by examiner]
KR 1020180016338A · 2018 [cited by applicant]
WO 2010019155A1 · 2010 [cited by applicant]
WO WO2010096868A1 · 2010 [cited by examiner]
WO 2016141450A1 · 2016 [cited by applicant]
Danaei, M. et al., pharmaceutics, 2018, 10, 1-17 (Year: 2018). [cited by examiner]
Gasparelo, A. P. et al., Zeta Potential and Particle Size to Predict Emulsion Stability, Cosmetics & Toiletries, 2014, 1-9, retrieved from https://www.cosmeticsandtoiletries.com on Apr. 29, 2025 (Year: 2014). [cited by examiner]
Medline, Traditional Wound Care, published Dec. 7, 2015, 1-49, retrieved from https://www.yumpu.com/en/document/view/49050741/traditional-wound-care-brochure-medline Apr. 28, 2025 (Year: 2015). [cited by examiner]
Rowe, R. C., Sheskey, P. J., & Owen, S. C. (2009). Handbook of Pharmaceutical excipients (6th ed.). APhA/Pharmaceutical Press (Year: 2009). [cited by examiner]
USDA, Chlorhexidine, NOSB Material Database, 2010, 1-5 (Year: 2010). [cited by examiner]
Brown, M.B. et al., (2011). Topical Product Formulation Development. In Topical and Transdermal Drug Delivery (eds H.A.E. Benson and A.C. Watkinson) (Year: 2011). [cited by examiner]
International Search Report issued for International Application No. PCT/KR2020/008139 on Sep. 22, 2020, 4 pages. [cited by applicant]